The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held
virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in …

Abstract The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie
(German Gynecological Oncology Group, AGO) presents the 2022 update of the evidence …

Purpose We aimed to assess the impact of surgery of primary tumor in overall survival (OS)
of women with de novo metastatic breast cancer. Methods Nationwide, population-based …

Inflammatory breast cancer (IBC) is a rare and aggressive breast cancer characterized by
erythema and edema of at least one-third of the breast. The diagnosis remains a clinical …

Prolonged survival of patients with stage IV breast cancer could change the role of
radiotherapy for local control of breast primary, but its survival benefit remains unclear. Our …

This text is based on the recommendations accepted by the 4th Hungarian Consensus
Conference on Breast Cancer, modified on the basis of the international consultation and …

Background For patients with de novo stage IV breast cancer (BC), the conditions under
which the primary tumor resection (PTR) may offer benefit remain unclear. Methods The …

Purpose We sought to assess survival outcomes of patients with de novo metastatic breast
cancer (dnMBC) who did not receive treatment irrespective of the reason. Methods Adults …

De novo metastatic breast cancer (dnMBC) accounts for~ 6–10% of all breast cancers and
for~ 30% of MBC with increasing incidence over time. Hormone receptor-positive/human …

Background Primary stage IV breast cancer is associated with a poor prognosis. At present,
the value of local surgical treatment for patients with stage IV breast cancer remains …